$1.32
1.49% day before yesterday
Nasdaq, Nov 28, 09:52 pm CET
ISIN
US69353Y1038
Symbol
PMVP

PMV Pharmaceuticals Inc Stock price

$1.32
-0.15 10.20% 1M
+0.42 46.65% 6M
-0.19 12.58% YTD
-0.28 17.50% 1Y
-8.26 86.22% 3Y
-33.92 96.25% 5Y
-16.68 92.67% 10Y
-16.68 92.67% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
-0.02 1.49%
ISIN
US69353Y1038
Symbol
PMVP
Industry

Key metrics

Basic
Market capitalization
$71.3m
Enterprise Value
$-58.0m
Net debt
positive
Cash
$129.3m
Shares outstanding
53.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.8
P/B
0.6
Financial Health
Equity Ratio
92.1%
Return on Equity
-33.3%
ROCE
-75.8%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-92.0m | $-98.2m
EBIT
$-92.1m | $-92.8m
Net Income
$-82.7m | $-84.3m
Free Cash Flow
$-73.1m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-18.4% | -16.5%
EBIT
-16.4% | -8.6%
Net Income
-60.7% | -43.6%
Free Cash Flow
-53.9%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-1.6
FCF per Share
$-1.4
Short interest
3.4%
Employees
47
Rev per Employee
$0.0
Show more

Is PMV Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

PMV Pharmaceuticals Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a PMV Pharmaceuticals Inc forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a PMV Pharmaceuticals Inc forecast:

Buy
92%
Hold
8%

Financial data from PMV Pharmaceuticals Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 24 24
16% 16%
-
- Research and Development Expense 68 68
17% 17%
-
-92 -92
18% 18%
-
- Depreciation and Amortization 0.14 0.14
90% 90%
-
EBIT (Operating Income) EBIT -92 -92
16% 16%
-
Net Profit -83 -83
61% 61%
-

In millions USD.

Don't miss a Thing! We will send you all news about PMV Pharmaceuticals Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PMV Pharmaceuticals Inc Stock News

Neutral
GlobeNewsWire
about one month ago
PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced updated data from the Phase 2 pivotal portion of the ongoing PYNNACLE clinical trial. Results were presented today in an oral pr...
Neutral
GlobeNewsWire
about 2 months ago
PRINCETON, N.J., Oct. 13, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that two abstracts have been accepted for oral and poster presentations at the upcoming AACR-NCI-EORTC International Conference ...
Neutral
GlobeNewsWire
3 months ago
PRINCETON, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced interim data from the Phase 2 pivotal portion of the PYNNACLE clinical trial. The ongoing Phase 1/2 PYNNACLE clinical trial is ...
More PMV Pharmaceuticals Inc News

Company Profile

PMV Pharmaceuticals, Inc. engages in the development of p53 targeted small molecule drugs for the treatment of cancer. It combines unique biological understanding with pharmaceutical development focus. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in 2013 and is headquartered in New Jersey, NY.

Head office United States
CEO David Mack
Employees 47
Founded 2013
Website www.pmvpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today